800 related articles for article (PubMed ID: 12533723)
41. DNA binding of USF is required for specific E-box dependent gene activation in vivo.
Kiermaier A; Gawn JM; Desbarats L; Saffrich R; Ansorge W; Farrell PJ; Eilers M; Packham G
Oncogene; 1999 Dec; 18(51):7200-11. PubMed ID: 10602473
[TBL] [Abstract][Full Text] [Related]
42. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
43. Characterization of the Basal promoter element of human organic cation transporter 2 gene.
Asaka J; Terada T; Ogasawara K; Katsura T; Inui K
J Pharmacol Exp Ther; 2007 May; 321(2):684-9. PubMed ID: 17314196
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional regulation of the human ABO histo-blood group genes is dependent on the N box upstream of the proximal promoter.
Kominato Y; Hata Y; Matsui K; Takizawa H; Tsukada J; Nakajima T; Kaneko Y; Kishi K
Transfusion; 2004 Dec; 44(12):1741-9. PubMed ID: 15584989
[TBL] [Abstract][Full Text] [Related]
45. Recognition of the E-C4 element from the C4 complement gene promoter by the upstream stimulatory factor-1 transcription factor.
Galibert MD; Boucontet L; Goding CR; Meo T
J Immunol; 1997 Dec; 159(12):6176-83. PubMed ID: 9550420
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the promoter of the gene encoding human tripeptidyl-peptidase II and identification of upstream silencer elements.
Lindås AC; Tomkinson B
Gene; 2007 May; 393(1-2):62-9. PubMed ID: 17343995
[TBL] [Abstract][Full Text] [Related]
47. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.
Warnecke C; Willich T; Holzmeister J; Bottari SP; Fleck E; Regitz-Zagrosek V
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):17-24. PubMed ID: 10229654
[TBL] [Abstract][Full Text] [Related]
48. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
49. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
Lieu PT; Wagner EK
Virology; 2000 Jun; 272(1):191-203. PubMed ID: 10873762
[TBL] [Abstract][Full Text] [Related]
50. Characterization of human and mouse angiopoietin-like factor CDT6 promoters.
Liu JJ; Wilson SE
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2776-83. PubMed ID: 11687517
[TBL] [Abstract][Full Text] [Related]
51. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation.
Uchiumi T; Kohno K; Tanimura H; Matsuo K; Sato S; Uchida Y; Kuwano M
Cell Growth Differ; 1993 Mar; 4(3):147-57. PubMed ID: 8466853
[TBL] [Abstract][Full Text] [Related]
52. Transcription of the human thyrotropin-releasing hormone receptor gene-analysis of basal promoter elements and glucocorticoid response elements.
Høvring PI; Matre V; Fjeldheim AK; Loseth OP; Gautvik KM
Biochem Biophys Res Commun; 1999 Apr; 257(3):829-34. PubMed ID: 10208868
[TBL] [Abstract][Full Text] [Related]
53. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells.
Lefort K; Rouault JP; Tondereau L; Magaud JP; Doré JF
Oncogene; 2001 Nov; 20(50):7375-85. PubMed ID: 11704867
[TBL] [Abstract][Full Text] [Related]
54. The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.
Couvineau A; Maoret JJ; Rouyer-Fessard C; Carrero I; Laburthe M
Biochem J; 2000 May; 347 Pt 3(Pt 3):623-32. PubMed ID: 10769164
[TBL] [Abstract][Full Text] [Related]
55. Functional analysis of the promoters of the human red and green visual pigment genes.
Shaaban SA; Deeb SS
Invest Ophthalmol Vis Sci; 1998 May; 39(6):885-96. PubMed ID: 9579468
[TBL] [Abstract][Full Text] [Related]
56. p53 Pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter.
Millau JF; Bastien N; Bouchard EF; Drouin R
Cancer Res; 2009 Nov; 69(21):8463-71. PubMed ID: 19843844
[TBL] [Abstract][Full Text] [Related]
57. Excitotoxic brain lesion modifies binding to a USF binding site acting as a negative regulatory element in the Protease nexin-1 promoter.
Ernø H; Küry P; Nitsch C; Jost JP; Monard D
Mol Cell Neurosci; 1996; 8(1):28-37. PubMed ID: 8923453
[TBL] [Abstract][Full Text] [Related]
58. Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site.
Tasheva ES; Maki CG; Conrad AH; Conrad GW
Biochim Biophys Acta; 2001 Feb; 1517(3):333-8. PubMed ID: 11342211
[TBL] [Abstract][Full Text] [Related]
59. Alpha-myosin heavy chain gene regulation: delineation and characterization of the cardiac muscle-specific enhancer and muscle-specific promoter.
Molkentin JD; Jobe SM; Markham BE
J Mol Cell Cardiol; 1996 Jun; 28(6):1211-25. PubMed ID: 8782063
[TBL] [Abstract][Full Text] [Related]
60. Analysis of the promoter region of human mimecan gene.
Tasheva ES
Biochim Biophys Acta; 2002 May; 1575(1-3):123-9. PubMed ID: 12020827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
